NYSE: IVZInvesco Ltd Stock
$21.12-0.22 (-1.03%)
Updated Aug 15, 2025
IVZ Price
$21.12
Fair Value Price
N/A
Market Cap
$9.42B
52 Week Low
$11.60
52 Week High
$21.85
P/E
22.71x
P/B
0.68x
P/S
1.15x
PEG
0.47x
Dividend Yield
2.96%
Revenue
$6.15B
Earnings
$422.90M
Gross Margin
100%
Operating Margin
12.31%
Profit Margin
0.5%
Debt to Equity
0.98
Operating Cash Flow
$1B
Beta
1.45
Next Earnings
N/A
Ex-Dividend
Aug 14, 2025
Next Dividend
Sep 2, 2025
IVZ Overview
Invesco Ltd. is an independent investment management company operating under the Invesco, Trimark, Invesco Perpetual, WL Ross & Co, and Powershares brand names. The company offers asset classes including money market, balanced, equity, fixed income, and alternatives with a range of investment strategies across asset classes, investment styles, and geographies. Invesco's client base includes public and private entities, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. Invesco was created in 1978 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IVZ's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
IVZ
Ranked#69 of 83
Ranked#69 of 83
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.45 | A | |
| $47.04 | A | |
| $143.54 | B |
Be the first to know about important IVZ news, forecast changes, insider trades & much more!
IVZ News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IVZ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IVZ ($21.12) is trading below its intrinsic value of $21.56, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVZ is good value based on its earnings relative to its share price (22.71x), compared to the US market average (35.99x)
P/E vs Market Valuation
IVZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more IVZ due diligence checks available for Premium users.
Valuation
IVZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.71x
Industry
49.22x
Market
35.99x
IVZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IVZ is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IVZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
3.07x
IVZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IVZ price to earnings growth (PEG)
For valuing profitable companies with growth potential
IVZ is good value based... subscribe to Premium to read more.
PEG Value Valuation
IVZ's financial health
Profit margin
Revenue
$1.5B
Net Income
-$12.5M
Profit Margin
-15.1%
IVZ's Earnings (EBIT) of $757.30M... subscribe to Premium to read more.
Interest Coverage Financials
IVZ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$28.5B
Liabilities
$13.5B
Debt to equity
0.98
IVZ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IVZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$547.9M
Investing
-$275.4M
Financing
-$724.8M
IVZ's operating cash flow ($1.22B)... subscribe to Premium to read more.
Debt Coverage Financials
IVZ vs Asset Management Stocks
Invesco Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.